{"transactions":[{"id":848342,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":61479,"kind":"person","name":"Davis Matthew W.","position":1,"cik":"0002094283","reported_name":"Davis Matthew W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2026-03-11T16:49:56.000Z","date":"2026-03-09","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment."}],"balance_after":50000,"derivative":{"exercise_price":4.29,"expiration_date":"2036-03-09","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001214659-26-003140","document":"marketforms-72466.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465926003140/marketforms-72466.xml","form_type":"4"}},{"id":848341,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":61479,"kind":"person","name":"Davis Matthew W.","position":1,"cik":"0002094283","reported_name":"Davis Matthew W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2026-03-11T16:49:56.000Z","date":"2026-03-09","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment."}],"balance_after":100000,"source":{"system":"sec-edgar","filing":"0001214659-26-003140","document":"marketforms-72466.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465926003140/marketforms-72466.xml","form_type":"4"}},{"id":1001643,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":61479,"kind":"person","name":"Davis Matthew W.","position":1,"cik":"0002094283","reported_name":"Davis Matthew W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2025-11-12T14:35:57.000Z","date":"2025-11-10","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment."}],"balance_after":50000,"derivative":{"exercise_price":5.58,"expiration_date":"2035-11-10","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001214659-25-016275","document":"marketforms-71182.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465925016275/marketforms-71182.xml","form_type":"4"}},{"id":1001642,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":61479,"kind":"person","name":"Davis Matthew W.","position":1,"cik":"0002094283","reported_name":"Davis Matthew W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2025-11-12T14:35:57.000Z","date":"2025-11-10","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment."}],"balance_after":50000,"source":{"system":"sec-edgar","filing":"0001214659-25-016275","document":"marketforms-71182.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465925016275/marketforms-71182.xml","form_type":"4"}}]}